New RAF-targeted therapeutic shows early promise against tumours with BRAF and RAS mutations
27 Apr 2016
New RAF-targeted therapeutic shows early promise against tumours with BRAF and RAS mutations
MINDACT breast cancer clinical trial: First results and impact on future trial design
Breast cancer research news from AACR President Nancy Davidson
BSH 2016: Expert discussion on front line care in CLL
BSH 2016: Expert discussion on idelalisib
SPF30 sunscreens delay melanoma incidence in preclinical model
Risk of breast cancer after chest radiotherapy may be affected by genetics
WIN 2016: Preview of themes
WIN 2016: Preview of Speakers
Immunotherapy and personalised medicine in review
Rationale for combining immunotherapy with chemotherapy
Bone pain management for cancer patients